about
Mainzer-Saldino syndrome is a ciliopathy caused by IFT140 mutationsRecessive mutations in DGKE cause atypical hemolytic-uremic syndromeSuccessful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome.Varicella as a trigger of atypical haemolytic uraemic syndrome associated with complement dysfunction: two cases.Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature.Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive SurveyEffect of hydrochlorothiazide on urinary calcium excretion in dent disease: an uncontrolled trial.Literature review and case histories of Histoplasma capsulatum var. duboisii infections in HIV-infected patients.Therapy for acute rejection in pediatric organ transplant recipients.Cytomegalovirus infection can mimic genetic nephrotic syndrome: a case reportComprehensive PKD1 and PKD2 Mutation Analysis in Prenatal Autosomal Dominant Polycystic Kidney Disease.LMX1B mutations cause hereditary FSGS without extrarenal involvementMutation Update of the CLCN5 Gene Responsible for Dent Disease 1.Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis.Age-Dependent Risk of Graft Failure in Young Kidney Transplant Recipients.Observations of a large Dent disease cohort.Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.Acute renal failure in a 3-year-old child as part of the drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome following hepatitis A.C3 nephritic factor associated with C3 glomerulopathy in children.Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome.Cryptosporidiosis in paediatric renal transplantation.Growth in boys with idiopathic nephrotic syndrome on long-term cyclosporin and steroid treatment.Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant.Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients.
P50
Q24313632-2EB2672A-7EE6-4F97-9176-FC6134B3F51FQ24337607-3F36A7B2-8E67-44D6-9798-38810F4D26E3Q33378897-D3AE9385-8291-44AC-9E9E-518947292238Q33384143-559C0675-B474-41E0-90ED-92E0427EC228Q33393574-68CEEB88-0071-4A81-B43A-D66A7E09C8C5Q33430541-C1A9A043-A38C-49B4-BB0B-FD8C6258FC35Q34599574-1FC4E7AB-702D-4B59-BC49-90DA69AC1A6CQ34740616-B3EEAF4A-6D18-4AD4-A204-3086C3BD7D19Q35045949-BA3E89E1-4B95-480E-8D4F-902285142B95Q35784264-25B0B6AF-2797-43F2-AE35-E14042F5BB99Q36624649-75D2F00A-946F-4992-8ED6-A30DC25A3860Q37078415-EFA81E33-8B73-40F6-8628-D8B510F3E8CAQ38439682-32864850-5C80-4A9A-BBCE-5AA22D63153AQ38638596-C10006A4-6C17-4485-B5CB-5FFE9EC82C89Q39534085-33F89EF9-A150-4CA3-BA3F-B9CADEB51FC4Q39656237-4F70FF75-FE85-49C1-B5EA-03708D365ECAQ39931551-810D1C91-52B4-4C9E-B5A2-D2BF68A3A41BQ40433657-733391AF-CD2B-4A0D-A80A-7235870B7C1DQ42246527-18F21552-3DF4-4D93-ADBB-338E210942A7Q42698311-23F6CEC7-85AE-4C37-9389-DBF0E5A33AD8Q43284412-ADCC70E6-C179-4701-8864-23D2ADD0D11BQ43294421-DA7B9240-9EFE-4570-AAB2-DD8B20E4EFDCQ43501079-0CA4CFF3-E583-4D21-8D75-7BD20C0A8F7AQ43570020-A4736F41-F219-4125-A2AE-5A0E4E8B49C1
P50
description
onderzoeker
@nl
name
Véronique Baudouin
@ast
Véronique Baudouin
@en
Véronique Baudouin
@es
Véronique Baudouin
@nl
Véronique Baudouin
@sl
type
label
Véronique Baudouin
@ast
Véronique Baudouin
@en
Véronique Baudouin
@es
Véronique Baudouin
@nl
Véronique Baudouin
@sl
altLabel
Veronique Baudouin
@en
prefLabel
Véronique Baudouin
@ast
Véronique Baudouin
@en
Véronique Baudouin
@es
Véronique Baudouin
@nl
Véronique Baudouin
@sl